PEDIATRÍA
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Biomedicina de Sevilla (2)
2024
-
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 12, pp. 1604-1615
2023
-
Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis
European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 4271-4284